• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Constitutes
Company Encyclopedia
View More
name
CNI BIOMEDICINE
399441.SZ
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

BGI Group CEO Yin Ye: The world will achieve "healthy aging" within one or two generations

In an exclusive interview with Global Times, BGI Group CEO Yin Ye stated that the world will achieve "centenarian health" within one or two generations. He emphasized China's rapid development in the field of biomanufacturing, particularly in the innovation of gene editing technology and biomedicine. Yin Ye believes that China is quickly catching up with developed countries in terms of original innovation from 0 to 1, and the future prospects of the biomanufacturing industry are immeasurable

Wallstreetcn·3 Hours ago
SZ
399441
+0.19%
Wallstreetcn·3 Hours ago
SZ
399441
+0.19%

The net profit of the Sci-Tech Innovation Board increased by 75% in the third quarter, and "hard technology" companies continue to increase their R&D investment

The 592 companies on the Sci-Tech Innovation Board saw a 75% year-on-year increase in net profit in the third quarter, indicating an overall performance rebound. Hard technology companies are increasing R&D investment, driving the development of industries such as integrated circuits, artificial intelligence, and biomedicine

Wallstreetcn·11/13/2025 22:00
SZ
399441
+0.19%
Wallstreetcn·11/13/2025 22:00
SZ
399441
+0.19%

Event Tracking

Nov20
Bailitianheng Signs Strategic Cooperation Agreement with Bank of China Sichuan Branch
02:45
Nov19
Jiangsu Province Launches Biomedicine Industry Chain Alliance and New Energy Industry Chain Platform
04:47
Nov18
Cao Xiaochun Completes Share Reduction Plan at Theragen Medical
14:15
JPMorgan Chase Reduces Position in KaiLai 70,700 Shares
10:47
Fosun Pharma Subsidiary Zhaohui Pharma Receives Approval for Polyethylene Glycol Electrolyte Powder Drug Registration Application
10:12
Mirxes Holding and Walvax Biotechnology Sign Strategic MOU on RNA-focused Medical Cooperation
08:35
Terms & Conditions
  • Terms of Service
  • Privacy Policy